Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally-Advanced Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00124618
What this trial is testing

Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 58
Large-scale testing (Phase 3)Study completedNCT00216125
What this trial is testing

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nasser Hanna, M.D. 243
Early research (Phase 1)Not Yet RecruitingNCT07699757
What this trial is testing

HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion

Who this might be right for
Non-Small Cell Lung CancerPancreatic Ductal Adenocarcinoma (mPDAC)Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd. 258
Testing effectiveness (Phase 2)Looking for participantsNCT05692635
What this trial is testing

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Who this might be right for
Brain MetastasesNonsmall Cell Lung Cancer Stage III
Wake Forest University Health Sciences 60
Early research (Phase 1)Study completedNCT00921739
What this trial is testing

Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies

Who this might be right for
Non Small Cell Lung CancerSmall Cell Lung CancerThymoma+1 more
Duke University 24
Early research (Phase 1)Active Not RecruitingNCT05653882
What this trial is testing

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerMelanoma+2 more
Asher Biotherapeutics, Inc. 552
Testing effectiveness (Phase 2)Study completedNCT00620971
What this trial is testing

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 77
Testing effectiveness (Phase 2)WithdrawnNCT00210171
What this trial is testing

Concomitant Chemo-radiotherapy in Locally Advanced Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Institut Bergonié
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07759492
What this trial is testing

Personnalized Immunotherapy in Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III Unresectable
Intergroupe Francophone de Cancerologie Thoracique 177
Testing effectiveness (Phase 2)Study completedNCT04647344
What this trial is testing

AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV
Akeso 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05548504
What this trial is testing

Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIRadiotherapy Side EffectFrailty
Odense University Hospital 182
Testing effectiveness (Phase 2)Study completedNCT01395758
What this trial is testing

Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 96
Testing effectiveness (Phase 2)Study completedNCT01222312
What this trial is testing

Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel

Who this might be right for
Non Small Cell Lung Cancer
Krankenhaus Nordwest 88
Large-scale testing (Phase 3)Study completedNCT00718315
What this trial is testing

Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 201
Large-scale testing (Phase 3)Active Not RecruitingNCT03706690
What this trial is testing

Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 407
Testing effectiveness (Phase 2)Study completedNCT03543813
What this trial is testing

PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL

Who this might be right for
Solid Tumor, AdultHead and Neck CancerNon Small Cell Lung Cancer+2 more
CytomX Therapeutics 133
Testing effectiveness (Phase 2)Study completedNCT02087423
What this trial is testing

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 446
Testing effectiveness (Phase 2)Looking for participantsNCT05967689
What this trial is testing

Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Who this might be right for
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
Taiho Oncology, Inc. 220
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06604351
What this trial is testing

Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 39
Next Page